Interaction between the antibiotic spiramycin and a ribosomal complex active in peptide bond formation.

The inhibition of peptide bond formation by spiramycin was studied in an in vitro system derived from Escherichia coli. Peptide bonds are formed between puromycin (S) and Ac-Phe-tRNA, which is a component of complex C, i.e., of the [Ac-Phe-tRNA-70S ribosome-poly(U)] complex, according to the puromycin reaction: C+S (Ks)<==>CS (k3)==>C'+P [Synetos, D., & Coutsogeorgopoulos, C. (1987) Biochim. Biophys. Acta 923, 275-285]. It is shown that spiramycin (A) reacts with complex C and forms the spiramycin complex C*A, which is inactive toward puromycin. C*A is the tightest complex formed between complex C and any of a number of antibiotics, such as chloramphenicol, blasticidin S, lincomycin, or sparsomycin. C*A remains stable following gel chromatography on Sephadex G-200 and sucrose gradient ultracentrifugation. Detailed kinetic study suggests that C*A is formed in a variation of a two-step mechanism in which the initial encounter complex CA is kinetically insignificant and C*A is the product of a conformational change of complex CA according to the equation, C+A (kassoc)<==>(kdissoc) C*A. The rate constants of this reaction (spiramycin reaction) are kassoc = 3.0 x 10(4) M-1 s-1 and kdissoc = 5.0 x 10(-5) s-1. Such values allow the classification of spiramycin as a slow-binding, slowly reversible inhibitor; they also lead to the calculation of an apparent overall dissociation constant equal to 1.8 nM for the C*A complex. Furthermore, they render spiramycin a useful tool in the study of antibiotic action on protein synthesis in vitro. Thus, the spiramycin reaction, in conjunction with the puromycin reaction, is applied (i) to detect a strong preincubation effect exerted by chloramphenicol and lincomycin (this effect constitutes further evidence that these two antibiotics combine with complex C as slow-binding inhibitors) and (ii) to determine the rate constant for the regeneration (k7 = 2.0 x 10(-3) s-1) of complex C from the sparsomycin complex C*I [Theocharis, D. A., & Coutsogeorgopoulos, C. (1992) Biochemistry 31, 5861-5868] according to the equation, C+I (Ki)<==>CI (k6)<==>(k7) C*I. The determination of k7 enables us to calculate the apparent association rate constant of sparsomycin, (k7/Ki') = 1.0 x 10(5) M-1 s-1, where Ki' = Ki(k7/k6 + k7). It is also shown that Ac-Phe-tRNA bound to the sparsomycin complex C*I is protected against attack by hydroxylamine.(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  C. Coutsogeorgopoulos,et al.  Slow-onset inhibition of ribosomal peptidyltransferase by lincomycin. , 1992, Archives of biochemistry and biophysics.

[2]  O. W. Odom,et al.  Use of 50 S-binding antibiotics to characterize the ribosomal site to which peptidyl-tRNA is bound. , 1992, The Journal of biological chemistry.

[3]  C. Coutsogeorgopoulos,et al.  Mechanism of action of sparsomycin in protein synthesis. , 1992, Biochemistry.

[4]  C Frieden,et al.  The rate of formation of transition-state analogues in the active site of adenosine deaminase is encounter-controlled: implications for the mechanism. , 1992, Biochemistry.

[5]  C. Coutsogeorgopoulos,et al.  Kinetics of inhibition of peptide bond formation on bacterial ribosomes. , 1992, Archives of biochemistry and biophysics.

[6]  O. W. Odom,et al.  The synthesis of polyphenylalanine on ribosomes to which erythromycin is bound. , 1991, European journal of biochemistry.

[7]  M. Di Giambattista,et al.  Affinity labeling of the virginiamycin S binding site on bacterial ribosome. , 1990, Biochemistry.

[8]  R. Marconi,et al.  Identification of a rRNA/chloramphenicol interaction site within the peptidyltransferase center of the 50 S subunit of the Escherichia coli ribosome. , 1990, The Journal of biological chemistry.

[9]  Harry F. Noller,et al.  Intermediate states in the movement of transfer RNA in the ribosome , 1989, Nature.

[10]  C. Coutsogeorgopoulos,et al.  Reactivity of the P-site-bound donor in ribosomal peptide-bond formation. , 1989, European journal of biochemistry.

[11]  C. Coutsogeorgopoulos,et al.  Recovery of active ribosomal complexes from cellulose nitrate membranes. , 1989, Analytical biochemistry.

[12]  C. Walsh,et al.  The behavior and significance of slow-binding enzyme inhibitors. , 2006, Advances in enzymology and related areas of molecular biology.

[13]  J. Schloss.  Significance of slow-binding enzyme inhibition and its relationship to reaction-intermediate analogs , 1988 .

[14]  B. Cooperman,et al.  [3H]-p-azidopuromycin photoaffinity labeling of Escherichia coli ribosomes: evidence for site-specific interaction at U-2504 and G-2502 in domain V of 23S ribosomal RNA. , 1988, Biochemistry.

[15]  O. W. Odom,et al.  An apparent conformational change in tRNA(Phe) that is associated with the peptidyl transferase reaction. , 1987, Biochimie.

[16]  E. Cundliffe,et al.  On the nature of antibiotic binding sites in ribosomes. , 1987, Biochimie.

[17]  Y. Engelborghs,et al.  Kinetics of binding of macrolides, lincosamides, and synergimycins to ribosomes. , 1987, The Journal of biological chemistry.

[18]  C. Walsh,et al.  1-Aminocyclopropanephosphonate: time-dependent inactivation of 1-aminocyclopropanecarboxylate deaminase and Bacillus stearothermophilus alanine racemase by slow dissociation behavior. , 1987, Biochemistry.

[19]  Carl Frieden,et al.  Adenosine deaminase: viscosity studies and the mechanism of binding of substrate and of ground- and transition-state analogue inhibitors. , 1987, Biochemistry.

[20]  C. Coutsogeorgopoulos,et al.  Inhibition of ribosomal peptidyltransferase by chloramphenicol , 1987 .

[21]  C. Coutsogeorgopoulos,et al.  Studies on the catalytic rate constant of ribosomal peptidyltransferase. , 1987, Biochimica et biophysica acta.

[22]  J. Tudela,et al.  Kinetic characterization of an enzymatic irreversible inhibition measured in the presence of coupling enzymes. The inhibition of adenosine triphosphatase from sarcoplasmic reticulum by fluorescein isothiocyanate. , 1987, Biochimica et biophysica acta.

[23]  B. Cooperman.  Photoaffinity labelling of Escherichia coli ribosomes , 1987 .

[24]  J. Ballesta,et al.  Reaction of some macrolide antibiotics with the ribosome. Labeling of the binding site components. , 1986, Biochemistry.

[25]  C. Tsou,et al.  Determination of rate constants for the irreversible inhibition of acetylcholine esterase by continuously monitoring the substrate reaction in the presence of the inhibitor. , 1986, Biochimica et biophysica acta.

[26]  J. Ballesta,et al.  Ribosome structure: binding site of macrolides studied by photoaffinity labeling. , 1985, Biochemistry.

[27]  W. Mangel,et al.  Theory and experimental method for determining individual kinetic constants of fast-acting, irreversible proteinase inhibitors. , 1984, Biochimica et biophysica acta.

[28]  Carl Frieden,et al.  Adenosine deaminase: solvent isotope and pH effects on the binding of transition-state and ground-state analogue inhibitors. , 1983, Biochemistry.

[29]  C. Tsou,et al.  Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier. , 1982, Biochemistry.

[30]  Carl Frieden,et al.  Adenosine deaminase and adenylate deaminase: comparative kinetic studies with transition state and ground state analogue inhibitors. , 1980, Biochemistry.

[31]  D. Vazquez.  Protein Synthesis and Translation Inhibitors , 1979 .

[32]  J. Morrison,et al.  [17] The kinetics of reversible tight-binding inhibition , 1979 .

[33]  J. Miller,et al.  Inhibitors of protein synthesis V. Irreversible interaction of antibiotics with an initiation complex. , 1975, Nucleic acids research.

[34]  S. Pestka.  Binding of [14C]Erythromycin to Escherichia coli Ribosomes , 1974, Antimicrobial Agents and Chemotherapy.

[35]  A. Jimenez,et al.  Interaction of Ac‐Phe‐tRNA with E. coli ribosomal subunits. 2. Resistance of the sparsomycin‐induced complex to hydroxylamine action , 1970, FEBS letters.

[36]  D. Vazquez.  Inhibitors of protein synthesis at the ribosome level. Studies on their site of action. , 1967, Life sciences.